Two Companies are Collaborating to Develop an Investigational Drug for Epidermolysis Bullosa
Two companies, GtreeBNT and YuYang DNU, will collaborate in a joint venture to develop the investigational drug RGN-137 for the treatment of epidermolysis bullosa. For more details, you can read…